Pedro is a seasoned expert in the implementation of technologies for public health and clinical trials. With over 12 years of experience, he has collaborated with a diverse range of municipalities in Brazil, global pharmaceutical companies, and research institutions. His work has positively impacted over 6 million people across 4,200 cities, including remote and underserved communities, and has been showcased in global medical congresses and journals. Currently, his cutting-edge platform, epScience, is running a major clinical trial involving 30 hospitals and 2,800 participants. epHealth has recently relocated its HQ to London, UK, as part of the UK’s Government Global Entrepreneur Programme (GEP), for establishing partnerships with renowned global institutions.